<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01468246</url>
  </required_header>
  <id_info>
    <org_study_id>06-169</org_study_id>
    <nct_id>NCT01468246</nct_id>
  </id_info>
  <brief_title>The Young Women's Breast Cancer Study</brief_title>
  <acronym>HOHO</acronym>
  <official_title>Helping Ourselves, Helping Others: The Young Women's Breast Cancer Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dana-Farber Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dana-Farber Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are conducting a longitudinal cohort study of young women with breast
      cancer. The investigators identify women age 40 and younger with newly-diagnosed breast
      cancer from academic and community healthcare institutions. After women consent to the study,
      they fill-out surveys and give blood samples, and the investigators collect tissue from their
      breast cancer tumor after it is removed. Women are surveyed every 6 months for the first 3
      years after diagnosis, then yearly thereafter for an additional 7 years (for a total
      follow-up of at least 10 years following diagnosis). The study investigates short and
      long-term disease and treatment issues, tumor biology and the relationship to patient
      outcomes, and psychosocial concerns at baseline and in follow-up among a cohort of young
      women who are newly-diagnosed with breast cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a longitudinal cohort study of young women with breast cancer. Over a 6-year period,
      the investigators aim to identify over 1,600 women age 40 and younger with newly diagnosed
      breast cancer from academic and community health care institutions. It is anticipated that
      1,300 of these women will agree to participate in an observational study. Patient surveys,
      medical record review, and blood and tissue collection will be utilized. Women will be
      surveyed every 6 months for the first 3 years after diagnosis, then yearly thereafter for an
      additional 7 years (for a total follow-up of 10 year following diagnosis). The study will
      investigate short and long-term disease and treatment issues, and psychosocial concerns at
      baseline and in follow-up among a cohort of young women (age 40 or younger) newly diagnosed
      with breast cancer. The investigators aim to characterize the population of young women at
      diagnosis and in follow-up regarding disease and psychosocial outcomes (e.g., presentation
      and disease characteristics, treatment patterns and quality of care, short and long-term side
      effects, and psychosocial concerns including fertility, sexual functioning, and menopausal
      issues). The investigators will also collect tumor and blood specimens to characterize the
      tumors, and bank for future studies including molecular evaluations of disease
      characteristics, genetic variability and hormonal levels in blood. Ultimately, the
      investigators aim to develop predictors of outcome, and identify areas that may be amenable
      to intervention.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Anticipated">January 2026</completion_date>
  <primary_completion_date type="Anticipated">November 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify a cohort of young women (age 40 or younger) newly diagnosed with breast cancer</measure>
    <time_frame>10 years</time_frame>
    <description>Characterize the population of young women at diagnosis and in follow-up regarding disease and psychosocial outcomes (e.g., presentation and disease characteristics including evaluating women with metastatic disease, reported frequency and factors associated with genetic testing, treatment patterns and quality of care, short and long-term side effects, and psychosocial concerns including fertility, sexual functioning, and menopausal issues).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specimen Collection</measure>
    <time_frame>10 years</time_frame>
    <description>Collect tumor and blood specimens to characterize the tumors, and bank for future studies including molecular evaluations of disease characteristics, genetic variability and hormonal levels in blood.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identify Predictors of Outcome</measure>
    <time_frame>10 years</time_frame>
    <description>Ultimately, the investigators aim to develop predictors of outcome and identify areas that may be amenable to intervention for young women with breast cancer.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1302</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Young Women</arm_group_label>
    <description>Young women with newly diagnosed breast cancer</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The investigators are collecting blood and tumor specimens.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study includes women who are newly-diagnosed with breast cancer. They must be 40 or
        younger at their diagnosis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Diagnosis of breast cancer

          -  Age 40 or younger at diagnosis

          -  Informed consent obtained from patient

          -  Ability to understand written and spoken English to the extent necessary to complete
             the questionnaires

        Exclusion Criteria:

          -  Inability to understand written and spoken English to the extent necessary to complete
             the questionnaires

          -  Absence of informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Peppercorn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Come, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Therese Mulvey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mass General/North-Shore Cancer Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Blair Ardman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lowell General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lawrence Blaszkowsky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Newton-Wellesley Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frank G Basile, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cape Cod Healthcare</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ellen Warner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Virginia Borges, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kathryn Ruddy, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katherina Zabicki Calvillo, MD, FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>South Shore Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeanna Walsh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dana-Farber/New Hampshire Oncology-Hematology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Natalie Sinclair, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>DF/BWCC at Milford Regional Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Cancer Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth-Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dana-Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MGH/North Shore Cancer Center</name>
      <address>
        <city>Danvers</city>
        <state>Massachusetts</state>
        <zip>01923</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cape Cod Hospital</name>
      <address>
        <city>Hyannis</city>
        <state>Massachusetts</state>
        <zip>02601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lowell General Hospital</name>
      <address>
        <city>Lowell</city>
        <state>Massachusetts</state>
        <zip>01854</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DF/BWCC at Milford Regional Medical Center</name>
      <address>
        <city>Milford</city>
        <state>Massachusetts</state>
        <zip>01757</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newton-Wellesley Hospital</name>
      <address>
        <city>Newton</city>
        <state>Massachusetts</state>
        <zip>02462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Shore Hospital</name>
      <address>
        <city>South Weymouth</city>
        <state>Massachusetts</state>
        <zip>02190</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dana-Farber/New Hampshire Oncology-Hematology</name>
      <address>
        <city>Londonderry</city>
        <state>New Hampshire</state>
        <zip>03053</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Goddard ET, Hill RC, Nemkov T, D'Alessandro A, Hansen KC, Maller O, Mongoue-Tchokote S, Mori M, Partridge AH, Borges VF, Schedin P. The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis. Cancer Discov. 2017 Feb;7(2):177-187. doi: 10.1158/2159-8290.CD-16-0822. Epub 2016 Dec 14.</citation>
    <PMID>27974414</PMID>
  </reference>
  <reference>
    <citation>Olsen SN, Wronski A, Casta√±o Z, Dake B, Malone C, De Raedt T, Enos M, DeRose YS, Zhou W, Guerra S, Loda M, Welm A, Partridge AH, McAllister SS, Kuperwasser C, Cichowski K. Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. Cancer Discov. 2017 Feb;7(2):202-217. doi: 10.1158/2159-8290.CD-16-0520. Epub 2016 Dec 14.</citation>
    <PMID>27974415</PMID>
  </reference>
  <results_reference>
    <citation>Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2012 Feb;131(3):1061-6. doi: 10.1007/s10549-011-1872-9. Epub 2011 Nov 13.</citation>
    <PMID>22080245</PMID>
  </results_reference>
  <results_reference>
    <citation>Rosenberg SM, Tamimi RM, Gelber S, Ruddy KJ, Kereakoglow S, Borges VF, Come SE, Schapira L, Winer EP, Partridge AH. Body image in recently diagnosed young women with early breast cancer. Psychooncology. 2013 Aug;22(8):1849-55. doi: 10.1002/pon.3221. Epub 2012 Nov 7.</citation>
    <PMID>23132765</PMID>
  </results_reference>
  <results_reference>
    <citation>Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, Troyan S, Morrow M, Schapira L, Come SE, Winer EP, Partridge AH. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013 Sep 17;159(6):373-81. doi: 10.7326/0003-4819-159-6-201309170-00003.</citation>
    <PMID>24042365</PMID>
  </results_reference>
  <results_reference>
    <citation>Ruddy KJ, Gelber S, Tamimi RM, Schapira L, Come SE, Meyer ME, Winer EP, Partridge AH. Breast cancer presentation and diagnostic delays in young women. Cancer. 2014 Jan 1;120(1):20-5. doi: 10.1002/cncr.28287. Epub 2013 Nov 11.</citation>
    <PMID>24347383</PMID>
  </results_reference>
  <results_reference>
    <citation>Ruddy KJ, Gelber SI, Tamimi RM, Ginsburg ES, Schapira L, Come SE, Borges VF, Meyer ME, Partridge AH. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014 Apr 10;32(11):1151-6. doi: 10.1200/JCO.2013.52.8877. Epub 2014 Feb 24.</citation>
    <PMID>24567428</PMID>
  </results_reference>
  <results_reference>
    <citation>Rosenberg SM, Tamimi RM, Gelber S, Ruddy KJ, Bober SL, Kereakoglow S, Borges VF, Come SE, Schapira L, Partridge AH. Treatment-related amenorrhea and sexual functioning in young breast cancer survivors. Cancer. 2014 Aug 1;120(15):2264-71. doi: 10.1002/cncr.28738. Epub 2014 May 28.</citation>
    <PMID>24891236</PMID>
  </results_reference>
  <results_reference>
    <citation>Rosenberg SM, Sepucha K, Ruddy KJ, Tamimi RM, Gelber S, Meyer ME, Schapira L, Come SE, Borges VF, Golshan M, Winer EP, Partridge AH. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer. Ann Surg Oncol. 2015 Nov;22(12):3809-15. doi: 10.1245/s10434-015-4572-6. Epub 2015 May 1.</citation>
    <PMID>25930247</PMID>
  </results_reference>
  <results_reference>
    <citation>Borstelmann NA, Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S, Borges V, Morgan E, Partridge AH. Partner support and anxiety in young women with breast cancer. Psychooncology. 2015 Dec;24(12):1679-85. doi: 10.1002/pon.3780. Epub 2015 Mar 13.</citation>
    <PMID>25765893</PMID>
  </results_reference>
  <results_reference>
    <citation>Collins LC, Gelber S, Marotti JD, White S, Ruddy K, Brachtel EF, Schapira L, Come SE, Borges VF, Schedin P, Warner E, Wensley T, Tamimi RM, Winer EP, Partridge AH. Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women. Oncologist. 2015 Jul;20(7):713-8. doi: 10.1634/theoncologist.2014-0412. Epub 2015 May 29.</citation>
    <PMID>26025931</PMID>
  </results_reference>
  <results_reference>
    <citation>Walker HE, Rosenberg SM, Stanton AL, Petrie KJ, Partridge AH. Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer. J Adolesc Young Adult Oncol. 2016 Mar;5(1):16-23. doi: 10.1089/jayao.2015.0051. Epub 2015 Dec 17.</citation>
    <PMID>26812461</PMID>
  </results_reference>
  <results_reference>
    <citation>Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S, Borges VF, Larsen B, Garber JE, Partridge AH. BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer. JAMA Oncol. 2016 Jun 1;2(6):730-6. doi: 10.1001/jamaoncol.2015.5941.</citation>
    <PMID>26867710</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2011</study_first_submitted>
  <study_first_submitted_qc>November 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2011</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dana-Farber Cancer Institute</investigator_affiliation>
    <investigator_full_name>Ann H. Partridge, MD, MPH</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>Cohort</keyword>
  <keyword>Young Women</keyword>
  <keyword>Survivorship</keyword>
  <keyword>Fertility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

